Phibro Animal Health

Recent news

• Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, Vs. FactSet Est of $381.2M
  MT Newswires · 2026/8/27
• Rating change
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $27
  Market Newswire · 2025/8/29
• Rating change
  Morgan Stanley Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Raises Target Price to $45
  Market Newswire · 2025/11/8
• Rating change
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating
  Market Newswire · 2026/6/12
• J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Announces Target Price $58
  Market Newswire · 2026/8/25
• Rating change
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $32
  Market Newswire · 2026/1/30
• Rating change
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $32
  Market Newswire · 2026/2/5
• J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Cuts Target Price to $55
  Market Newswire · 2026/9/2
• Rating change
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $62
  Market Newswire · 2026/4/16
• Rating change
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/28
• Rating change
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $58
  Market Newswire · 2026/2/9
• Rating change
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $27
  Market Newswire · 2025/8/29
• Rating change
  J.P. Morgan Maintains Phibro Animal Health(PAHC.US) With Buy Rating, Raises Target Price to $50
  Market Newswire · 2025/11/7
• Rating change
  BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $38
  Market Newswire · 2026/2/6
• Rating change
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Maintains Target Price $44
  Market Newswire · 2026/5/14
• Form 144 | Phibro Animal Health(PAHC.US) 10% Stockholder Proposes to Sell 12.36 Million in Common Stocks
  Market Newswire · 2026/9/17
• Rating change
  J.P. Morgan Reaffirms Their Buy Rating on Phibro Animal Health (PAHC)
  TipRanks · 2025/9/1
• Rating change
  Citi Maintains Phibro Animal Health(PAHC.US) With Hold Rating, Cuts Target Price to $44
  Market Newswire · 2026/5/14
• Rating change
  Citi Initiates Phibro Animal Health(PAHC.US) With Hold Rating, Announces Target Price $62
  Market Newswire · 2026/4/15
• BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating
  Market Newswire · 2026/7/28

Headlines are aggregated automatically and are not independently verified or edited by our team.